Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. Different from the traditional “cell-animal model – human body” medical research and development path, Unknown uses an innovative research model and a unique drug research and development platform to “artificial intelligence + bioinformatics technology” and intestinal micro-ecology The combination of technologies has greatly improved the research and development efficiency and success rate of new drugs.